Advertisement
Advertisement
U.S. markets close in 4 hours 15 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Acorda Therapeutics, Inc. (ACOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.71000.0000 (0.00%)
As of 11:45AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close2.7100
Open2.7300
Bid2.7100 x 1000
Ask2.7500 x 1400
Day's Range2.6500 - 2.7500
52 Week Range2.3400 - 8.6600
Volume78,151
Avg. Volume152,452
Market Cap30.358M
Beta (5Y Monthly)0.52
PE Ratio (TTM)N/A
EPS (TTM)-17.0410
Earnings DateMar 02, 2022 - Mar 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACOR

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acorda Therapeutics, Inc.
    ACOR: Lowering target price to $0.64ACORDA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $0.635200; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
Advertisement
Advertisement